Literature DB >> 15749143

Modulation of natural killer cell activity by supplementation of fermented milk containing Lactobacillus casei in habitual smokers.

Kanehisa Morimoto1, Tatsuya Takeshita, Masanobu Nanno, Shinkan Tokudome, Kunio Nakayama.   

Abstract

BACKGROUND: Habitual smoking significantly reduces natural killer (NK) cell activity. To clarify whether the intake of fermented milk containing lactic acid bacteria restores NK cell activity in habitual smokers, we conducted a placebo-controlled double-blind test.
METHODS: Ninety-nine subjects with smoking habits were randomly divided into two groups and daily for 3 weeks were given fermented milk containing Lactobacillus casei or placebo. NK cell activity in the peripheral blood mononuclear cells (PBMNC) was determined before and after the intake. Average number of cigarettes smoked and number of cigarettes that the subjects smoked before giving blood after getting up on the inspection day were asked, and these data were used to adjust the influence of smoking on NK cell activity.
RESULTS: NK cell activity in individuals was inversely correlated to numbers of cigarettes smoked. Averaged NK cell activity adjusted by the numbers of cigarettes was significantly higher in individuals drinking fermented milk containing L. casei than those drinking a placebo. However, the proportion of NK cells was not different between individuals drinking either fermented milk containing L. casei or the placebo.
CONCLUSIONS: Intake of fermented milk containing lactic acid bacteria was considered effective for restoring the NK cell activity of habitual smokers.

Entities:  

Mesh:

Year:  2005        PMID: 15749143     DOI: 10.1016/j.ypmed.2004.07.019

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  21 in total

1.  Long-term effects of lifestyle on multiple risk factors in male workers.

Authors:  Hanayo Koetaka; Yuko Ohno; Kanehisa Morimoto
Journal:  Environ Health Prev Med       Date:  2009-03-07       Impact factor: 3.674

Review 2.  Compositional dynamics of the human intestinal microbiota with aging: implications for health.

Authors:  B Lakshminarayanan; C Stanton; P W O'Toole; R P Ross
Journal:  J Nutr Health Aging       Date:  2014-11       Impact factor: 4.075

3.  Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers.

Authors:  Honglin Dong; Ian Rowland; Linda V Thomas; Parveen Yaqoob
Journal:  Eur J Nutr       Date:  2013-01-10       Impact factor: 5.614

4.  Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota.

Authors:  K Takeda; T Suzuki; S-I Shimada; K Shida; M Nanno; K Okumura
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

5.  Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity.

Authors:  Kan Shida; Tomomi Suzuki; Junko Kiyoshima-Shibata; Shin-Ichiro Shimada; Masanobu Nanno
Journal:  Clin Vaccine Immunol       Date:  2006-09

Review 6.  Impact of Lung Microbiota on COPD.

Authors:  Cristina Russo; Valeria Colaianni; Giuseppe Ielo; Maria Stella Valle; Lucia Spicuzza; Lucia Malaguarnera
Journal:  Biomedicines       Date:  2022-06-06

Review 7.  Probiotics and immunity.

Authors:  Andrea T Borchers; Carlo Selmi; Frederick J Meyers; Carl L Keen; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2009-01-22       Impact factor: 7.527

Review 8.  Role of natural killer and dendritic cell crosstalk in immunomodulation by commensal bacteria probiotics.

Authors:  Valeria Rizzello; Irene Bonaccorsi; Maria Luisa Dongarrà; Lisbeth Nielsen Fink; Guido Ferlazzo
Journal:  J Biomed Biotechnol       Date:  2011-05-03

9.  Yearly changes in the composition of gut microbiota in the elderly, and the effect of lactobacilli intake on these changes.

Authors:  Ryuta Amamoto; Kazuhito Shimamoto; Sungjin Park; Hoshitaka Matsumoto; Kensuke Shimizu; Miyuki Katto; Hirokazu Tsuji; Satoshi Matsubara; Roy J Shephard; Yukitoshi Aoyagi
Journal:  Sci Rep       Date:  2021-06-17       Impact factor: 4.379

Review 10.  Probiotics in the management of lung diseases.

Authors:  Esmaeil Mortaz; Ian M Adcock; Gert Folkerts; Peter J Barnes; Arjan Paul Vos; Johan Garssen
Journal:  Mediators Inflamm       Date:  2013-05-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.